Search for Clinical Trial Results
Cerebellar Diseases - 25 Studies Found
Status | Study |
Completed |
Study Name: An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) Condition: Spinocerebellar Degeneration Date: 2013-10-22 Interventions:
|
Completed |
Study Name: A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) Condition: Spinocerebellar Degeneration Date: 2013-10-22 Interventions:
|
Completed |
Study Name: A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) Condition: SCD Date: 2011-06-23 Interventions:
|
Completed |
Study Name: A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) Condition: Spinocerebellar Degeneration Date: 2009-10-27 Interventions:
|
Completed |
Study Name: Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) Condition: Spinocerebellar Degeneration Date: 2009-03-16 Interventions: Drug: KPS-0373 |
Completed |
Study Name: High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration Condition: Spinocerebellar Degenerations Date: 2002-04-24 Interventions: Drug: high-dose intravenous immunoglobulin (IVIG) |
Completed |
Study Name: The EUROSCA Natural History Study Condition: Spinocerebellar Ataxia Date: 2015-05-01 |
Recruiting |
Study Name: Machado-Joseph Disease in Israel Condition: Spinocerebellar Ataxia 3 Date: 2014-06-22 |
Completed |
Study Name: Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease Condition: Machado-Joseph Disease / Spinocerebellar Ataxia 3 Date: 2014-05-21 Interventions:
|
Active, not recruiting |
Study Name: Effect of Nicotinamide in Friedreich's Ataxia Condition: Neurodegenerative Disorders Date: 2012-02-20 Interventions: Drug: nicotinamide dose-escalation, 2-8 grams, oral |